Position in NTRA
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$5,619,319
-$419,951 QoQ
Shares Held
28,098
+6.6% QoQ
Ownership
0.020%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NTRA Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026STOREBRAND ASSET MANAGEMENT AS holds $242,137,436 across 12 Diagnostics & Research names. NTRA ranks #7 (2.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
210,751 | $103,590,439 | |
| 2 | DHR |
Danaher Corp /De/
|
341,082 | $64,669,147 | |
| 3 | DGX |
Quest Diagnostics Inc
|
140,574 | $27,549,692 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
23,371 | $13,131,931 | |
| 5 | A |
Agilent Technologies, Inc.
|
95,831 | $10,922,817 | |
| 6 | WAT |
Waters Corp /De/
|
23,339 | $6,950,354 | |
| 7 | NTRA |
Natera, Inc.
This page
|
28,098 | $5,619,319 | |
| 8 | IQV |
Iqvia Holdings Inc.
|
17,647 | $3,009,519 |
All Filings in NTRA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,619,319 | 28,098 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $6,039,270 | 26,362 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $3,900,625 | 24,232 | Shares | Sole | 2026-06-03 | |
| 2025-06-30 | $3,962,825 | 23,457 | Shares | Sole | 2026-06-03 | |
| 2025-03-31 | $2,096,827 | 14,828 | Shares | Sole | 2026-06-03 | |
| No filing history on record for this holder in this stock. | ||||||